Trials / Enrolling By Invitation
Enrolling By InvitationNCT06793683
Early BOTOX After Spinal Cord Injury
Early Detrusor Chemodenervation to Preserve Bladder Compliance and Longevity After Spinal Cord Injury
- Status
- Enrolling By Invitation
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- University of Washington · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The investigators would like to improve our understanding of how early intervention with the use of bladder chemodenervation can preserve bladder function in those with a new SCI. Although detrimental cystometric and tissue changes are known to occur, often within 3 months after SCI, the investigators seek to document the time course of these changes and the range of severity of those changes in both those participants that receive prophylactic treatment and those who do not.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bladder chemodenervation (Botox) | BoNT-A (Botox) 200 U will be injected into the detrusor (bladder wall muscle). |
| PROCEDURE | Bladder Sham (Saline) Injection Procedure | 20mL placebo (saline only), will be injected into the detrusor (bladder wall muscle). |
Timeline
- Start date
- 2024-07-27
- Primary completion
- 2028-04-30
- Completion
- 2028-09-30
- First posted
- 2025-01-27
- Last updated
- 2025-01-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06793683. Inclusion in this directory is not an endorsement.